Form 4 Tracker
Tango Therapeutics, Inc.
TNGX

17 insider filings · Latest: Jun 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2026Jun 17 8:45 PMNextech Crossover I SCSp
Proposed Sale
3,766,081$30.10$113.4M

View →

Jun 11, 2026Jun 11 10:00 PMDANIELLA BECKMAN
Proposed Sale
1,791,726$28.76$51.5M

View →

Jun 10, 2026Jun 10 8:45 PMDANIELLA BECKMAN
Proposed Sale
4,446$30.00$133.4K

View →

Jun 1, 2026Jun 3 10:37 PMAdam CrystalPresident, R&D
Sale
27,000$22.87$617.6K115,743(D)

View →

May 1, 2026May 5 11:47 PMAdam CrystalPresident, R&D
Sale
27,000$21.23$573.1K115,743(D)

View →

May 1, 2026May 1 8:48 PMADAM CRYSTAL
Proposed Sale
65,460$21.62$1.4M

View →

Apr 15, 2026Apr 17 12:14 AMAdam CrystalPresident, R&D
Sale
38,460$25.00$961.5K112,622(D)

View →

Apr 1, 2026Apr 3 12:09 AMAdam CrystalPresident, R&D
Sale
27,000$21.20$572.5K112,622(D)

View →

Mar 25, 2026Mar 28 12:06 AMAdam CrystalPresident, R&D
Sale
12,000$20.11$241.3K112,622(D)

View →

Mar 25, 2026Mar 25 8:24 PMADAM CRYSTAL
Proposed Sale
93,000$19.48$1.8M

View →

Mar 5, 2026Mar 9 8:01 PMAdam CrystalPresident, R&D
Sale
20,251$15.00$303.8K112,622(D)

View →

Mar 5, 2026Mar 5 9:52 PMADAM CRYSTAL
Proposed Sale
20,251$12.35$250.1K

View →

Feb 25, 2026Feb 27 11:54 PMAdam CrystalPresident, R&D
Sale
54,345$12.77$694.2K132,873(D)

View →

Feb 25, 2026Feb 25 9:36 PMADAM CRYSTAL
Proposed Sale
54,345$12.88$700.0K

View →

Feb 3, 2026Feb 5 1:12 AMDaniella BeckmanChief Financial Officer
Sale
10,317$12.26$126.5K184,297(D)

View →

Feb 3, 2026Feb 5 1:09 AMBarbara WeberDirector, Director, Executive Chair
Sale
30,519$12.26$374.3K1,629,254(D)

View →

Feb 3, 2026Feb 5 1:02 AMAdam CrystalPresident, R&D
Sale
18,452$12.26$226.3K187,218(D)

View →

Oct 23, 2025Oct 23 9:10 PMThird Rock Ventures IV, L.P.
Proposed Sale
477,401$7.53$3.6M

View →

Sep 25, 2025Sep 25 8:58 PMThird Rock Ventures IV, L.P.
Proposed Sale
500,000$7.80$3.9M

View →

Sep 16, 2025Sep 17 2:29 PMThird Rock Ventures IV, L.P.
Proposed Sale
363,541$7.35$2.7M

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 19, 2026Jun 23 10:10 PMRobert AzelbyDirector
Grant/Award
35,910$27.9735,910(D)

View →

Jun 5, 2026Jun 8 10:08 PMJohn B KetchumDirector
Grant/Award
25,000$20.2225,000(D)

View →

Jun 5, 2026Jun 8 10:01 PMLesley Ann CalhounDirector
Grant/Award
25,000$20.2225,000(D)

View →

Jun 5, 2026Jun 8 9:55 PMMace RothenbergDirector
Grant/Award
25,000$20.2225,000(D)

View →

Jun 5, 2026Jun 8 9:49 PMSung LeeDirector
Grant/Award
3,570$20.223,570(D)

View →

Jun 1, 2026Jun 3 10:37 PMAdam CrystalPresident, R&D
Option Exercise
27,000$5.20341,040(D)

View →

May 1, 2026May 5 11:47 PMAdam CrystalPresident, R&D
Option Exercise
27,000$5.20368,040(D)

View →

May 1, 2026May 5 11:46 PMMatthew GallChief Financial Officer
Grant/Award
240,000$20.98240,000(D)

View →

Apr 29, 2026May 1 9:26 PMSung LeeDirector
Grant/Award
5,200$22.065,200(D)

View →

Apr 15, 2026Apr 17 12:14 AMAdam CrystalPresident, R&D
Option Exercise
38,460$5.20395,040(D)

View →

Apr 1, 2026Apr 3 12:09 AMAdam CrystalPresident, R&D
Option Exercise
27,000$5.20433,500(D)

View →

Mar 25, 2026Mar 28 12:06 AMAdam CrystalPresident, R&D
Option Exercise
12,000$5.20460,500(D)

View →

Feb 2, 2026Feb 5 1:12 AMDaniella BeckmanChief Financial Officer
Grant/Award
265,980$11.94265,980(D)

View →

Feb 2, 2026Feb 5 1:09 AMBarbara WeberDirector, Director, Executive Chair
Grant/Award
222,132$11.94222,132(D)

View →

Feb 2, 2026Feb 5 1:02 AMAdam CrystalPresident, R&D
Grant/Award
284,760$11.94284,760(D)

View →